Despite early Medicaid expansion, decreased durable virologic suppression among publicly insured people with HIV in Washington, DC: a retrospective analysis

by Deborah Goldstein, W. David Hardy, Anne Monroe, Qingjiang Hou, Rachel Hart, Arpi Terzian, on behalf of the DC Cohort Executive Committee
Published 2020-04-01

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens.

by Gregory D Huhn, Moti Ramgopal, Mamta K Jain, Federico Hinestrosa, David M Asmuth, Jihad Slim, Deborah Goldstein, Shauna Applin, Julie H Ryu, Shuping Jiang, Stephanie Cox, Moupali Das, Thai Nguyen-Cleary, David Piontkowsky, Bill Guyer, Lorenzo Rossaro, Richard H Haubrich
Published 2020-01-01

Incidence and Risk Factors for Renal Disease in an Outpatient Cohort of HIV-Infected Patients on Antiretroviral Therapy

by Saumil Doshi, Martin Ucanda, Rachel Hart, Qingjiang Hou, Arpi S. Terzian, Thilakavathy Subramanian, Jeffery Binkley, Rob Taylor, Nabil Rayeed, Cheryl Akridge, Stacey Purinton, Jeff Naughton, Lawrence D'Angelo, Michael Kharfen, Angela Wood, Michael Serlin, Princy Kumar, David Parenti, Amanda Castel, Alan Greenberg, Anne Monroe, Lindsey Powers Happ, Maria Jaurretche, Brittany Lewis, James Peterson, Naji Younes, Ronald Wilcox, Sohail Rana, Michael Horberg, Ricardo Fernandez, Annick Hebou, Carl Dieffenbach, Henry Masur, Jose Bordon, Gebeyehu Teferi, Debra Benator, Maria Elena Ruiz, Deborah Goldstein, David Hardy
Published 2019-08-01